
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: IINNW (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $0
1 Year Target Price $0
0 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 81.68% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 2.12 | 52 Weeks Range 0.12 - 0.99 | Updated Date 06/14/2025 |
52 Weeks Range 0.12 - 0.99 | Updated Date 06/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.67 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -81.03% | Return on Equity (TTM) -219.74% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 24090830 |
Shares Outstanding - | Shares Floating 24090830 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Inspira Technologies Oxy B.H.N. Ltd. Warrant
Company Overview
History and Background
Inspira Technologies Oxy B.H.N. Ltd. is a medical technology company specializing in respiratory support technology. The Warrant, INSP.WS, gives the holder the right to purchase shares of INSP stock at a specified price within a specific period.
Core Business Areas
- Respiratory Support Technology: Development and commercialization of respiratory support devices, primarily focusing on early intervention and less invasive solutions.
Leadership and Structure
Inspira Technologies is led by a management team with experience in medical device development and commercialization. The organizational structure is typical of a publicly traded company, with a board of directors overseeing management.
Top Products and Market Share
Key Offerings
- ARTRA: A less invasive respiratory support system designed to prevent the need for mechanical ventilation. Market share is currently negligible as the product is in pre-commercialization. Competitors include traditional ventilator manufacturers (e.g., Medtronic, Hamilton Medical) and companies developing alternative respiratory support devices.
Market Dynamics
Industry Overview
The respiratory support device market is driven by factors such as an aging population, increasing prevalence of respiratory diseases, and technological advancements. The market is competitive with established players and emerging companies offering innovative solutions.
Positioning
Inspira Technologies aims to disrupt the respiratory support market with its less invasive ARTRA system. Their competitive advantage lies in its potential to reduce the need for mechanical ventilation and associated complications.
Total Addressable Market (TAM)
The total addressable market for respiratory support devices is estimated to be in the billions of dollars. Inspira Technologies is positioned to capture a share of this market with its ARTRA system, targeting early intervention and less invasive respiratory support.
Upturn SWOT Analysis
Strengths
- Innovative technology (ARTRA system)
- Potential to reduce need for mechanical ventilation
- Focus on early intervention
Weaknesses
- Pre-commercialization stage
- Limited market presence
- Dependence on regulatory approvals
- Limited financial resources
Opportunities
- Growing demand for less invasive respiratory support solutions
- Partnerships with hospitals and healthcare providers
- Expansion into new markets
- Technological advancements in respiratory care
Threats
- Competition from established players
- Regulatory hurdles
- Reimbursement challenges
- Technological obsolescence
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Hamilton Medical (Private)
- Getinge (GETI-B.ST)
Competitive Landscape
Inspira Technologies faces significant competition from established players with greater resources and market presence. Its success depends on the ability to differentiate its ARTRA system and secure market adoption.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited due to pre-commercialization status.
Future Projections: Future growth is dependent on successful commercialization of the ARTRA system and securing partnerships. Analyst estimates should be consulted for specific projections.
Recent Initiatives: Recent initiatives include securing regulatory approvals and establishing manufacturing partnerships.
Summary
Inspira Technologies is a pre-commercialization company with an innovative respiratory support system that has the potential to disrupt the market. Their strength lies in the ARTRA system's potential to be less invasive. However, it faces significant challenges related to competition, regulatory approvals, and limited financial resources. Successful commercialization and partnerships are crucial for future growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings
- Industry reports
- Analyst research reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and consultation with a financial professional. Market share estimates are approximate and based on publicly available information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Inspira Technologies Oxy B.H.N. Ltd. Warrant
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-07-14 | Co-Founder, CEO & Director Mr. Dagi Shahar Ben-Noon | ||
Sector Healthcare | Industry Medical Devices | Full time employees 37 | Website https://inspira-technologies.com |
Full time employees 37 | Website https://inspira-technologies.com |
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.